Top Industry Leaders in the Immunotherapy Drugs market
Latest Immunotherapy Drugs Companies Updates:
AstraZeneca acquires ADC Therapeutics: This $5.2 billion deal strengthens AstraZeneca's oncology pipeline, specifically expanding its presence in antibody-drug conjugates (ADCs) used in immunotherapy.
Pfizer returns Bavencio rights to Merck KGaA: While this shake-up might seem surprising, it allows Pfizer to focus on its core oncology portfolio and gain royalties on future Bavencio sales.
Merck's Keytruda expands reach: New FDA approvals for treating non-small cell lung cancer and cervical cancer solidify Keytruda's dominance in the market.
Bristol Myers Squibb's Opdivo scores big: Opdivo, another leading checkpoint inhibitor, receives FDA approval for a new combination therapy in advanced bladder cancer.
List of Immunotherapy Drugs Key companies in the market:
- Hoffmann-La Roche AG
- GlaxoSmithKline
- AbbVie, Inc.
- Amgen, Inc.
- Merck & Co., Inc.
- Bristol-Myers Squibb
- Novartis International AG
- Eli Lilly and Company
- Johnson & Johnson
- AstraZeneca plc